Publication
Exploring MV14 as a nitric oxide-releasing strategy for bladder cancer: From synthesis to in vivo evaluation.
Miriam López, María Varela, Mariana Ingold, María Laura Lavaggi, Martín Breijo, Florencia Fontes, Marcelo Fernández, José Manuel Verdes, Juan Manuel Ramirez-Reyes, Victoria Yozzi, Camila Romero, Rosina Dapueto, Ana Laura Reyes, Manuela Bentura, Eduardo Savio, Paula Céspedes, Karen Perelmuter, Mariela Bollati-Fogolín, Gloria V López, Paola Hernández
- Source
- PubMed
- Retrieved
- Sep 30, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260930-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Bladder cancer remains a significant clinical challenge due to high recurrence rates and limited therapeutic options. Herein, we report the synthesis and biological evaluation of MV14, a nitric oxide-releasing compound with promising antitumor activity against bladder cancer. MV14 reduced cell…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Bladder Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available